NO970847D0 - 2-£amino-6-(cyklopropylamino)-9H-purin-9-yl|-2-cyklopenten-1-metanol-succinat som anti-virusmiddel - Google Patents

2-£amino-6-(cyklopropylamino)-9H-purin-9-yl|-2-cyklopenten-1-metanol-succinat som anti-virusmiddel

Info

Publication number
NO970847D0
NO970847D0 NO970847A NO970847A NO970847D0 NO 970847 D0 NO970847 D0 NO 970847D0 NO 970847 A NO970847 A NO 970847A NO 970847 A NO970847 A NO 970847A NO 970847 D0 NO970847 D0 NO 970847D0
Authority
NO
Norway
Prior art keywords
purin
cyclopropylamino
amino
cyclopenten
viral agent
Prior art date
Application number
NO970847A
Other languages
English (en)
Other versions
NO315200B1 (no
NO970847L (no
Inventor
Susan Mary Daluge
Jeffrey Douglas Wilson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO970847D0 publication Critical patent/NO970847D0/no
Publication of NO970847L publication Critical patent/NO970847L/no
Publication of NO315200B1 publication Critical patent/NO315200B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seasonings (AREA)
NO19970847A 1994-08-26 1997-02-25 2-[amino-6-(cyklopropylamino)-9H-purin-9-yl]-2-cyklopenten-1- metanol-succinat, anvendelse og fremstilling derav og farmasöytisk formuleringinneholdende dette NO315200B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9417249A GB9417249D0 (en) 1994-08-26 1994-08-26 A novel salt
PCT/GB1995/002014 WO1996006844A1 (en) 1994-08-26 1995-08-25 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent

Publications (3)

Publication Number Publication Date
NO970847D0 true NO970847D0 (no) 1997-02-25
NO970847L NO970847L (no) 1997-02-25
NO315200B1 NO315200B1 (no) 2003-07-28

Family

ID=10760434

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970847A NO315200B1 (no) 1994-08-26 1997-02-25 2-[amino-6-(cyklopropylamino)-9H-purin-9-yl]-2-cyklopenten-1- metanol-succinat, anvendelse og fremstilling derav og farmasöytisk formuleringinneholdende dette

Country Status (23)

Country Link
EP (1) EP0777669B1 (no)
JP (1) JPH10505593A (no)
KR (1) KR100376240B1 (no)
CN (1) CN1051550C (no)
AT (1) ATE220067T1 (no)
AU (1) AU702618B2 (no)
BR (1) BR9508629A (no)
CA (1) CA2198010C (no)
DE (1) DE69527294T2 (no)
DK (1) DK0777669T3 (no)
ES (1) ES2179110T3 (no)
FI (1) FI120403B (no)
GB (1) GB9417249D0 (no)
HU (1) HU221302B1 (no)
IL (1) IL115074A (no)
MX (1) MX9701273A (no)
NO (1) NO315200B1 (no)
NZ (1) NZ291862A (no)
PT (1) PT777669E (no)
RU (1) RU2145324C1 (no)
SI (1) SI0777669T1 (no)
WO (1) WO1996006844A1 (no)
ZA (1) ZA957166B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115461A (en) 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
PE74799A1 (es) * 1997-05-17 1999-08-13 Glaxo Group Ltd Combinaciones antivirales
BR9809124A (pt) * 1997-05-17 2000-08-01 Glaxo Group Ltd Combinação, formulação, farmacêutica, processo para o tratamento de uma infecção por hiv em um animal, infectado, uso de (-)-(1s, 4r)-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-cicl openteno-1-metanol, e, pacote de paciente
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
CZ298144B6 (cs) * 1997-11-27 2007-07-04 Lonza Ag Zpusob výroby (1S,4R)- nebo (1R,4S)-4-(2-amino-6-chlor-9-H-purin-9-yl)-2-cyklopenten-1-methanolu
GB9802472D0 (en) * 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
WO2003011221A2 (en) 2001-07-30 2003-02-13 University Of Southern California PREPARATION AND USE OF α-KETO PHOSPHONATES
CN1870998B (zh) * 2003-10-27 2010-10-20 默沙东公司 Ccr-2拮抗剂盐
EP2305680A3 (en) * 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
CN103282369A (zh) 2011-04-08 2013-09-04 劳乐斯实验室私营有限公司 抗逆转录病毒化合物与抗氧化酸的固体形式、其制备方法以及其药物组合物
EP2962693B1 (en) 2013-02-27 2019-01-09 Kyoto University Pharmaceutical composition comprising abacavir for the treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025492A1 (de) * 1980-07-04 1982-02-04 Siemens AG, 1000 Berlin und 8000 München Filterelement fuer die optische nachrichtentechnik
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate

Also Published As

Publication number Publication date
AU3350995A (en) 1996-03-22
GB9417249D0 (en) 1994-10-19
JPH10505593A (ja) 1998-06-02
BR9508629A (pt) 1997-11-25
EP0777669B1 (en) 2002-07-03
CN1051550C (zh) 2000-04-19
IL115074A0 (en) 1995-12-08
FI970786A0 (fi) 1997-02-25
DK0777669T3 (da) 2002-10-28
KR100376240B1 (ko) 2003-06-11
FI120403B (fi) 2009-10-15
RU2145324C1 (ru) 2000-02-10
HU221302B1 (en) 2002-09-28
IL115074A (en) 1998-10-30
SI0777669T1 (en) 2002-12-31
DE69527294D1 (en) 2002-08-08
FI970786A (fi) 1997-02-25
MX9701273A (es) 1997-05-31
CN1156456A (zh) 1997-08-06
ES2179110T3 (es) 2003-01-16
AU702618B2 (en) 1999-02-25
NO315200B1 (no) 2003-07-28
PT777669E (pt) 2002-11-29
KR970705563A (ko) 1997-10-09
WO1996006844A1 (en) 1996-03-07
DE69527294T2 (de) 2003-02-13
ZA957166B (en) 1997-02-25
CA2198010C (en) 2006-05-02
NO970847L (no) 1997-02-25
NZ291862A (en) 1998-02-26
CA2198010A1 (en) 1996-03-07
HUT77222A (hu) 1998-03-02
EP0777669A1 (en) 1997-06-11
ATE220067T1 (de) 2002-07-15

Similar Documents

Publication Publication Date Title
MY107843A (en) Anti-viral compounds.
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
CA2293470A1 (en) Benzimidazole derivatives
TW371660B (en) Therapeutic nucleosides a purine carbocyclic nucleosides for treatment of HIV and HBV infections
MY117892A (en) Therapeutic compounds
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
DE68922903D1 (de) Antivirale Pyrimidin- und Purinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate.
EP0349242A3 (en) Therapeutic nucleosides
NO970847D0 (no) 2-£amino-6-(cyklopropylamino)-9H-purin-9-yl|-2-cyklopenten-1-metanol-succinat som anti-virusmiddel
NZ324380A (en) Therapeutic benzimidazole compounds and their use in treatment of virus infections
AU7806187A (en) Sulphonamide derivatives for the treatment and prevention of viral diseases
GR3032621T3 (en) Extracts of piliostigma thonningii, the use thereof and formulations containing them.
CA2193665A1 (en) Benzimidazole derivatives for the treatment and prophylaxis of virus infections

Legal Events

Date Code Title Description
MK1K Patent expired